Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2026 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

metlife inc. - MET

MET

Close Chg Chg %
99.69 -1.43 -1.43%

Closed Market

98.27

-1.43 (1.43%)

Volume: 3.33M

Last Updated:

Nov 6, 2026, 3:59 PM EDT

Trade Now

Company Overview: metlife inc. - MET

MET Key Data

Open

$97.78

 Day Range

97.78 - 99.51

52 Week Range

67.33 - 106.72

 Market Cap

$65.38B

Shares Outstanding

635.48M

 Public Float

531.46M

Beta

0.78

 Rev. Per Employee

N/A

P/E Ratio

13.40

 EPS

$7.73

Yield

232.58%

 Dividend

$0.59

EX-DIVIDEND DATE

Nov 3, 2026

 SHORT INTEREST

N/A

AVERAGE VOLUME

3.18M

  

MET Performance

1 Week
 
 -0.27%
 
1 Month
 
 1.44%
 
3 Months
 
 2.03%
 
1 Year
 
 30.99%
 
5 Years
 
 55.88%
 

MET Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 22
Full Ratings ➔

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 110.533
Number of Ratings 22 Current Quarters Estimate 2.623
FY Report Date 12 / 2026 Current Year's Estimate 10.23
Last Quarter’s Earnings 2.78 Median PE on CY Estimate N/A
Year Ago Earnings 8.83 Next Fiscal Year Estimate 11.145
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 16 14 18 18
Mean Estimate 2.62 2.57 10.23 11.14
High Estimates 2.86 2.78 10.48 11.65
Low Estimate 2.41 2.39 10.02 10.76
Coefficient of Variance 3.86 4.80 1.14 2.48

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 12 12 11
OVERWEIGHT 3 3 3
HOLD 6 6 6
UNDERWEIGHT 1 1 2
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Metlife Inc. - MET

Date Name Shares Transaction Value
Oct 6, 2026 William E. Kennard Director 48,248 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $94.35 per share 4,552,198.80
Oct 6, 2026 Robert Glenn Hubbard Director 109,132 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $94.35 per share 10,296,604.20
Oct 6, 2026 Daniel S. Glaser Director 3,249 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $94.35 per share 306,543.15
Oct 6, 2026 Christian Mumenthaler Director 4,018 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $94.35 per share 379,098.30
Oct 6, 2026 Carla A. Harris Director 11,701 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $94.35 per share 1,103,989.35
Oct 6, 2026 Michelle Renae Seitz Director 2,125 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Oct 6, 2026 Diana L. McKenzie Director 25,929 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $94.35 per share 2,446,401.15
Oct 6, 2026 Mark Alan Weinberger Director 19,932 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Oct 6, 2026 Jeh Charles Johnson Director 10,101 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $94.35 per share 953,029.35
Oct 6, 2026 Laura J. Hay Director 6,901 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $94.35 per share 651,109.35
Sep 11, 2026 Ramy Tadros President, U.S. Business 212,695 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $95.5 per share 20,312,372.50

Metlife Inc. in the News